ArticleJournal of managed care & specialty pharmacy2020

ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine.

Meg Franklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.